Masimo Corporation
MASI US
MASI USMasimo Corporation
United States Composite136.14
Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
- Business
- Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Company News
Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report?
Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report?
Reasons Why You Should Retain Masimo (MASI) Stock for Now
Masimo (MASI) Gains Nearly 18% YTD: What's Driving the Rally?
Masimo (MASI) Gains Nearly 18% YTD: What's Driving the Rally?
Is a Beat Likely for Intuitive Surgical (ISRG) in Q1 Earnings?
Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
Here are the stocks set to have the wildest ride this week on earnings
Stocks making the biggest moves midday: Tesla, Goldman Sachs, Salesforce and more
Here are Monday's biggest analyst calls: Nvidia, Apple, Meta, Intel, Cisco, Reddit, Netflix, IBM, MGM & more
Stocks making the biggest moves premarket: Goldman Sachs, Snap One, Salesforce and more
Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 24% Undervaluation?
Another proxy battle unfolds in the health tech industry
Apple asks US appeals court to reverse Apple Watch import ban
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False Claims
Masimo faces another proxy challenge from Politan Capital
Can Mixed Fundamentals Have A Negative Impact on Masimo Corporation (NASDAQ:MASI) Current Share Price Momentum?
Is Masimo (MASI) Stock Outpacing Its Medical Peers This Year?